| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683104 Cholesterol and triglyceride-modulating drugs and methods |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/22/2004 | WO2004006834A2 Leflunomide analogs for treating rheumatoid arthritis |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | US20040014983 Chlorinating benzisoxazole methane sulfonic acid with thionyl chloride to form an intermediate of benzisoxazole methane sulfonamide |
| 01/22/2004 | US20040014968 Such as 2-(3-chloro-phenyl)-3-cyclopentyl-N-thiazol-2-yl-propionamide which increases insulin secretion in treatment of type II diabetes |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381369A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence |
| 01/21/2004 | CN1469748A Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 01/20/2004 | US6680387 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 01/20/2004 | US6680319 Treatment of obstructive syndromes of the lower urinary tract, including benign prostatic hyperplasia, treatment of lower urinary tract symptoms |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/14/2004 | EP1379513A1 Prodrugs of cox-2 inhibitors |
| 01/14/2004 | EP1379279A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine |
| 01/14/2004 | EP1379136A1 Preparation of ketones from aldehydes |
| 01/14/2004 | EP1155004B1 Method crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677458 Process for the preparation of 1,2-benzisoxazole-3-acetic acid |
| 01/13/2004 | US6677369 Antithrombotic agents |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002530A1 Remedy for chronic disease |
| 01/08/2004 | WO2004002409A2 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006100 Administering phenylacetic acid derivative for therapy of Parkinson's disease |
| 01/08/2004 | US20040005637 Intermediate products coupled to solid polymeric support suitable for synthesis of heterocyclic compounds in simple and fast methods on solid phase; for synthesis of heterocycles with large structural diversity in high yields |
| 01/08/2004 | CA2489428A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/06/2004 | US6673824 Phenyl sulfonamide endothelin antagonists |
| 01/06/2004 | US6673818 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| 01/06/2004 | US6673800 4,5,-dihydroisoxazolylakylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/02/2004 | EP1375499A1 Process for the production of 2-(5-methyl-4-oxazolyl)ethanol derivatives |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1374871A1 Crystalline isoxazole derivative and medical preparation thereof |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373229A1 Process for the preparation of 1,2-benzisoxazole-3-acetic acid |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372645A1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/02/2004 | EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002522 Antiinflammatory agents; analgesics |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2003088959A3 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 12/31/2003 | CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
| 12/30/2003 | US6670482 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes |
| 12/30/2003 | US6670358 Substituted thioacetamides |
| 12/30/2003 | US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 12/30/2003 | CA2088840C 4-benzoyl isoxazole herbicides |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/25/2003 | US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/25/2003 | US20030236294 Anticancer agents |
| 12/25/2003 | US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents |
| 12/25/2003 | US20030236227 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 12/24/2003 | WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation |
| 12/23/2003 | US6667404 Retroviral protease inhibiting compounds |
| 12/23/2003 | US6667342 Benzenesulfonamide-derivatives and their use as medicaments |
| 12/23/2003 | US6667333 Herbicidal 3-(4,5 dihydroisoxazole- 3 yl) substituted benzoycyclohexenone derivatives |
| 12/23/2003 | US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 12/18/2003 | US20030232871 Crystalline parecoxib sodium |
| 12/18/2003 | US20030232867 Comprises (2Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl) phenyl)-2-hepten-6-ynamide for preventing/treating chronic rejection in a transplanted organ or tissue |
| 12/18/2003 | US20030232863 Cathepsin cysteine protease inhibitors |
| 12/18/2003 | US20030232802 Aryl and heteroaryl sulfonates |
| 12/17/2003 | EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 12/17/2003 | EP1370520A1 Aryl and biaryl compounds having mch modulatory activity |
| 12/17/2003 | EP1226131B1 Isoxazolecarboxamide derivatives |
| 12/16/2003 | CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 12/11/2003 | WO2003101933A1 Intermediate products, methods for their preparation and use thereof |
| 12/11/2003 | WO2003078392A3 Process for preparing crystalline form i of cabergoline |
| 12/11/2003 | WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances |
| 12/11/2003 | US20030229232 Herbicides |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | CA2487659A1 Intermediate products, methods for their preparation and use thereof |
| 12/10/2003 | EP1368358A1 Isoxazoline derivatives as anti-depressants |
| 12/10/2003 | EP1368308A1 Cannabinoid receptor ligands |
| 12/10/2003 | EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 12/10/2003 | CN1461294A Method for producing beta ketoenol esters |
| 12/10/2003 | CN1130361C Process for producing isooxazolidinedione compound |
| 12/10/2003 | CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin |
| 12/09/2003 | US6660466 Reacting reactive appendage compounds such as meta benzylic compounds or alpha-amide compounds with scaffold molecules having reactive functionalities and contacting the intermediate library with a reducing agent |
| 12/09/2003 | CA2123697C Novel substituted salicylic acids |
| 12/09/2003 | CA2022425C 1,3,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |